熊果酸通过过氧化物酶增殖受体α和γ信号通路改善KKAy小鼠肝脏胰岛素抵抗的机制

doi:10.3736/jcim20120710

Abstract

Objective: To explore the effects and mechanism of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes.
Methods: Thirty-five KKAy mice were divided into five groups according to the randomized block design, namely, control, rosiglitazone, fenofibrate, and high- and low-dose ursolic acid groups with seven mice in each group. C57BL/6J mice were used as the normal control group. At the end of the 4th week, free fatty acid (FFA), tumor necrosis factor-α (TNF-α) and adiponectin contents in serum were detected by enzyme-linked immunosorbent assay; the protein expressions of phosphoenolpyruvate carboxykinase (PEPCK), insulin receptor substrate-2 (IRS-2) and glucose transport factor-2 (GLUT-2) were detected by Western blot method; the mRNA expressions of PEPCK, IRS-2 and GLUT-2 were detected by real-time polymerase chain reaction; the expressions of peroxisome proliferator-activated receptor α (PPARα) and peroxisome proliferator-activated receptor γ (PPARγ) in liver tissue were detected by immunohistochemical method.
Results: After four weeks of intervention, the contents of FFA, TNF-α and adiponectin in serum of the high-dose ursolic acid group had changed, showing statistically significant difference compared to those of the control group (P<0.01); high dose of ursolic acid had depressant effect on the expressions of PEPCK protein and PEPCK mRNA (P<0.01); low dose of ursolic acid depressed the expression of PEPCK mRNA and induced phosphorylation of IRS-2 in the liver (P<0.05); both high and low dose of ursolic acid improved the expression of PPARα in the liver (P<0.01).
Conclusion: The effects of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes may be closely related to affecting the contents of FFA, TNF-α and adiponectin, improving the expression of PPARα protein, regulating transcription of PEPCK protein and inducing phosphorylation of IRS-2.

Key words: hypoglycemic agents (TCD), ursolic acid, PPARα, PPARγ, insulin resistance, diabetes mellitus, experimental, procetofen, mice

Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20120710

http://www.jcimjournal.com/EN/Y2012/V10/I7/793

TrendMD

Figures/Tables 5

Table 1

Figure 1

Table 2

Table 3

Figure 2

References 7

[1]	Zhang J, Wu SY, Wang L, Wang GL, Zhu DZ . Effects of ursolic acid on fat metabolism in high-fat-fed induced insulin resistance rats[J]. Zhonghua Zhong Yi Yao Xue Kan, 2010,28(5):975-978
	张杰, 吴淑艳, 王琳, 王冠梁, 朱德增 . 熊果酸对高脂饮食诱导胰岛素抵抗大鼠脂质代谢的影响[J]. 中华中医药学刊, 2010,28(5):975-978
[2]	Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, Suzuki S, Kitamura KI, Sato N . Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone[J]. J Pharmacol Exp Ther, 2003,306(3):846-854 doi: 10.1124/jpet.102.047217
[3]	Chen CC, Hsu CY, Chen CY, Liu HK . Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death[J]. J Ethnopharmacol, 2008,117(3):483-490 doi: 10.1016/j.jep.2008.02.032
[4]	Wu S, Lu FE . Role of insulin receptor substrate 2 in pancreatic β-cell[J]. Guo Ji Nei Fen Mi Dai Xie Za Zhi, 2009,29(5):349-350, 353
	邬姗, 陆付耳 . 胰岛素受体底物-2对胰岛β细胞的作用[J]. 国际内分泌代谢杂志, 2009,29(5):349-350, 353
[5]	Chen SQ, Li H, Liu Q . The effect of high-fat diet on IRS-1 and IRS-2 expression of fatty liver in rat[J]. Zhongguo Tang Niao Bing Za Zhi, 2008,16(7):409-412
	陈世清, 黎华, 刘杞 . 高脂饮食对大鼠脂肪肝胰岛素受体底物1、2表达的影响[J]. 中国糖尿病杂志, 2008,16(7):409-412
[6]	Wang SH, Wang WJ . Pathogenesis of insulin resistance and prevention and treatment strategy of integrated traditional Chinese and Western medicine[J]. J Chin Integr Med, 2004,2(1):14-16 doi: 10.3736/jcim20040106
	王树海, 王文健 . 胰岛素抵抗的发病机制及中西医结合防治策略[J]. 中西医结合学报, 2004,2(1):14-16 doi: 10.3736/jcim20040106
[7]	He YM, Wang WJ, Chen WH, Ying J . Effects of Pollen Typhae total flavones on mRNA expressions of peroxisome proliferator-activated receptors in 3T3-L1 adipocytes[J]. J Chin Integr Med, 2008,6(9):939-941
	何燕铭, 王文健, 陈伟华, 应健 . 蒲黄总黄酮对3T3-L1脂肪细胞过氧化物酶体增生物激活受体家族mRNA基因表达的影响[J]. 中西医结合学报, 2008,6(9):939-941

Related Articles 15

[1]	Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[2]	Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[3]	Yunita Sari, Akhyarul Anam, Annas Sumeru, Eman Sutrisna. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. Journal of Integrative Medicine, 2021, 19(4): 347-353.
[4]	Abdulhakim Abubakar, Abdullahi Balarabe Nazifi, Idris Mohammed Maje, Yusuf Tanko, Joseph Akpojo Anuka, Ezzeldin Mukthar Abdurahman. Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4. Journal of Integrative Medicine, 2021, 19(1): 78-84.
[5]	Pukar Khanal, Basanagouda M. Patil. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.. Journal of Integrative Medicine, 2021, 19(1): 66-77.
[6]	Baoyi Shao, Saiying Hou, Yuenyan Chan, Changchun Shao, Lixing Lao. Remission of new-onset type 2 diabetes mellitus in an adolescent using an integrative medicine approach: A case report. Journal of Integrative Medicine, 2021, 19(1): 85-88.
[7]	Jafar Abolghasemi, Mohammad Ali Farboodniay Jahromi, Mohammad Hossein Sharifi, Zohreh Mazloom, Leila Hosseini, Nasrindokht Zamani, Majid Nimrouzi. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial. Journal of Integrative Medicine, 2020, 18(5): 401-408.
[8]	Esmaeil Yousefi Rad, Behzad Nazarian, Somayeh Saboori, Ebrahim Falahi, Azita Hekmatdoost. Effects of L-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials. Journal of Integrative Medicine, 2020, 18(4): 284-291.
[9]	Mohadeseh Ostovar, Abolfazl Akbari, Mohammad Hossein Anbardar, Aida Iraji, Mohsen Salmanpour, Salar Hafez Ghoran, Mojtaba Heydari, Mesbah Shams. Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy. Journal of Integrative Medicine, 2020, 18(1): 59-67.
[10]	Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[11]	Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[12]	Bérénice Colleville, Nicolas Perzo, Guillaume Avinée, Anaïs Dumesnil, Frederic Ziegler, Paul Billoir, Hélène Eltchaninoff, Vincent Richard, Eric Durand. Impact of high-fat diet and vitamin D₃ supplementation on aortic stenosis establishment in waved-2 epidermal growth factor receptor mutant mice. Journal of Integrative Medicine, 2019, 17(2): 107-114.
[13]	Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334.
[14]	Olakunle Bamikole Afolabi, Omotade Ibidun Oloyede, Shadrack Oludare Agunbiade. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe²⁺-induced pancreatic oxidative stress. Journal of Integrative Medicine, 2018, 16(3): 192-198.
[15]	Chun-song Hu, Tengiz Tkebuchava. SEEDi^1.0-3.0 strategies for major noncommunicable diseases in China. Journal of Integrative Medicine, 2017, 15(4): 265-269.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2]	Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3]	Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4]	Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5]	. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6]	Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7]	Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8]	Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9]	Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10]	Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228

Group	n	FFA (μmol/L)	TNF-α (ng/L)	Adiponectin (mg/L)
Normal	7	74.33±7.69^{**△△▲▲}	78.64±1.16^**	19.52±0.09^**△△
Control	7	427.32±9.31^▲▲	133.45±1.60^△△	4.13±0.12^▲▲
Rosiglitazone	7	352.68±9.15^▲▲	92.74±1.86^**	6.77±0.06^*
Fenofibrate	6	192.54±85.48^**△△	103.85±1.61^**	10.19±0.37^**△
UA 300 mL/(kg·d)	7	250.29±8.08^*△	105.42±1.27^*	6.82±0.10^▲
UA 150 mL/(kg·d)	6	341.45±151.41^▲▲	131.85±1.97^△△	5.79±0.05^▲

Group	n	PEPCK	GLUT-2	IRS-2
Normal	7	10.86±1.15^**	15.04±0.88^**	5.41±0.57^**
Control	7	18.37±1.29^△△	10.20±1.49	1.23±0.34
Rosiglitazone	7	12.45±1.26^**	11.63±0.83	1.63±0.17
Fenofibrate	6	15.97±1.47	13.59±0.95	1.34±0.12
UA 300 mL/(kg·d)	7	13.02±0.95^**△	11.15±1.33	2.38±0.27
UA 150 mL/(kg·d)	6	14.18±0.92^*	12.72±1.09	2.39±0.21

Group	n	PPARα	PPARγ
Normal	3	3.73±0.21^**	2.78±0.13
Control	3	1.53±0.15^▲▲	2.61±0.36
Rosiglitazone	3	1.84±0.26^▲	3.04±0.21
Fenofibrate	3	2.21±0.27^**△△	3.13±0.38
UA 300 mL/(kg·d)	3	3.10±0.34^**△△	2.72±0.07
UA 150 mL/(kg·d)	3	3.07±0.22^**△△	3.06±0.31

Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ

RichHTML

PDF (PC)

Like